Global brokerages cautious on PB Fintech as IRDAI draft triggers 36% crash

The latest market report highlights that A clear consensus has formed across brokerage notes published after IRDAI’s consultation paper: pure distribution platforms sit at the sharp end of the proposed changes, and PB Fintech is the most exposed listed name.

Bernstein called the cuts “far more severe than anticipated” and “ugly,” saying PB Fintech’s unit economics unravel at the proposed take-rate marks, especially in health and motor. The brokerage anticipates near-term stock-price pressure and significant industry pushback.

Macquarie estimated that a roughly two-percentage-point compression in take rates could erode EBITDA by around 25%, all else equal, and described the overall measures as steep enough to weigh on industry expansion while the sector recalibrates.

Jefferies put the earnings impact of a 10% trimmed in new-business commissions at 10-12% for PB Fintech and Turtlemint, noting limited scope for insurers to cushion distributors through operating expenses because of the tighter expense-of-management caps.

HSBC placed PB Fintech among the names that could see elevated potential impact, alongside HDFC Life and Max Financial, while viewing SBI Life as relatively least affected.

Investec went further on health, flagging a 60-70% trimmed in renewal commissions for the segment. Life insurance, by contrast, is described as more manageable because trail commissions have been boosted.

Kotak stated PB Fintech would have to “ride through tough times” and that it would revisit estimates once the firm’s strategy response becomes clearer.

Investec further noted that it would not view the regulatory-fuelled correction in PB Fintech as a bottom-fishing opportunity.

The draft does not treat every distributor the same.

Commission ceilings are elevated for individual agents than for distribution entities: the category that covers banks, brokers and web aggregators such as Policybazaar. In health, agents would be allowed 20% on new business and 10% on renewals; entities face 15% and 5%.

Similar gaps appear across pure-term and savings products. Macquarie and Kotak both note that the framework rewards “selling effort” over “distribution leverage.” In practice, it reduces the economic edge that open platforms built by offering customers choice across multiple insurers. Investec described the overall regulation as “overly stringent,” with proposed rates set well below prevailing market marks. Upfront commissions in life are trimmed by around 40% while trail is increased; credit-life faces a 90%+ reduction in places; motor commissions are capped 60-80% softer; and health sees 25-30% cuts on new business alongside the steeper renewal reduction.

Banks and NBFCs are additionally in the firing line.

Multi-tie-up banks that earned an average 33% total payout on life new business face a steeper reset than single-tie arrangements that averaged 13%, according to IRDAI data cited across the notes. JM Financial and Macquarie both flag Axis and HDFC as more exposed than SBI, ICICI or Kotak on this measure. Axis Bank’s insurance income accounted for 12.5% of PBT in FY26, the highest among large private banks tracked by JM. Credit-life commissions, which form a material share of earnings for several NBFCs, are proposed to be trimmed by roughly 75%. LTF has been flagged as particularly vulnerable, with insurance commissions contributing around 26% of its FY26 PBT and 80 basis points of average assets according to JM; Kotak additionally called it the worst hit among NBFCs. Other names with elevated exposure include Poonawalla, CIFC, HDB and MMFS. JM further noted that small finance banks show high dependence relative to their balance sheets, with insurance income ranging from 13-25 basis points of assets.

On the insurer side, the picture is less uniform.

Expense-of-management limits are being lowered on a glide path: 15% within two years and 12.5% within five for life firms, with a tighter 10% goal for those already below benchmark; general insurers move to 25% and then 20%. Large, softer-cost players are anticipated to absorb the tighter ceiling more easily. SBI Life, Canara HSBC Life and LIC are repeatedly cited as least impacted. Kotak retains a positive stance on life firms, with SBI Life and HDFC Life as top picks, and sees possible benefits for ICICI Lombard and stand-alone health insurers from softer motor commissions and volume upside in health once price elasticity plays through. HSBC places SBI Life at the softer end of the impact spectrum. Investec’s preferred picks stay Max Financial, Canara HSBC Life and Star Health.

Smaller insurers may find the new limits harder to meet, raising the prospect of further consolidation: a point both Kotak and Investec highlight.

The draft additionally tightens enforcement through mandatory cost audits and restrictions on related-party outsourcing, closing routes that previously allowed payouts to sit outside formal commission caps.

One open question runs through several notes.

Softer distribution costs could, in theory, backing more competitive pricing and elevated volumes. Investec asks the opposite: if incentives to distributors are trimmed this sharply, will sales momentum itself slow, undercutting the regulator’s broader goal of raising insurance penetration? Most houses expect significant industry pushback during the consultation window, which stays open until 25 October. Final numbers may soften.

What the brokerage notes are already underscoring, that stated, is the direction of travel. The sharpest pressure falls on open multi-insurer platforms, credit-life heavy lenders and multi-tie banks. PB Fintech is the clearest listed expression of that exposure.

Global research firms wary on PB Fintech as IRDAI draft triggers 36% crash

PB Fintech shares plunged as much as 36% on Thursday to hit a fresh 52-week low of around Rs 1,207. The stock opened near Rs 1,698 against the previous close of Rs 1,886 and saw heavy volumes exceeding 2.7 crore shares, with multiple softer-circuit hits during the session.